Sibylla Biotech Appoints Usman Azam CEO, Gianluca Fuggetta CFO, and Expands Executive Team to Drive Transition to Clinic
Sibylla Biotech, a private Milan-based oncology biotech, appointed Usman Azam, MD, as CEO and Gianluca Fuggetta as CFO as it prepares to advance its Cyclin D1-targeting folding-interference degrader into first-in-human studies. Co-founder and former CEO Lidia Pieri stays on as COO, and Elena Ardini was promoted to Chief Scientific Officer.
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.